A
$ Value
$0
Shares
147,000
Price
$0
Filed
Jul 28
Insider
Name
Ghias Babar
Title
CFO & Head of Corp Development
CIK
0002076862
Roles
Officer
Transaction Details
Transaction Date
2025-07-24
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
147,000
Footnotes
Inducement grant of restricted stock units pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan, as amended and restated (the "Stock Incentive Plan"), which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant. | Inducement grant of employee stock options pursuant to the Stock Incentive Plan, which will become exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.
Filing Info
Ghias Babar's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-12-17 | BCRX | A | $0 |
| 2025-12-17 | BCRX | A | $0 |
| 2025-07-24 | BCRX | A | $0 |
| 2025-07-24 | BCRX | A | $0 |
Other Insiders at BCRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| MILANO VINCENT | — | — | 2026-02-27 |
| Stonehouse Jon P | — | — | 2026-03-02 |
| Frank Steven | — | — | 2026-02-27 |
|
Barnes Alane P
Chief Legal Officer
|
— | $1.4M | 2026-03-16 |
| Milne Jill C. | — | — | 2026-02-27 |
| HEGGIE THERESA | — | $505K | 2026-03-20 |
| McKee Amy E | — | — | 2026-02-27 |
|
Menon Sandeep
Chief R&D Officer
|
— | — | 2026-04-06 |